Blog

Image: Tumour Heterogeneity The NHS in UK has finally approved Kadcyla, Roche Pharmaceuticals breast cancer drug, for routine use after a four-year campaign. The drug extends the lives of women with advanced forms of breast cancer by some six months. It was hitherto only available on a case-by-case basis through the Cancer Drugs Fund because…

Cervical Cancer A decade of non-animal tested cancer research funding by Caring Cancer Trust for the University of Manchester Viral Oncology Laboratories was celebrated at a recent University Philanthropy Circle inauguration.  Professor Dame Nancy Rothwell, President and Vice Chancellor of the University, is pictured with the Charity Chairman Chris Ody and Hon. Secretary Ian MacWatt.…